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Longevity & Healthspan, a new BioMed Central journal, has launched a thematic series on cellular senescence and
aging, a quickly evolving field critical to our understanding of the biology of aging.Aging occurs at virtually every level of complexity [1].
Two fundamental cellular aging processes have been de-
scribed: chronological and replicative [2]. Chronological
aging is of paramount importance in terminally differen-
tiated cells. An important component of chronological
aging is a breakdown in the balance between biosyn-
thesis, repair and turnover of macromolecules. Replica-
tive aging reflects the ability of a cell, and its lineage, to
support ongoing rounds of cell division, and is of major
importance in complex metazoan organisms whose adult
bodies depend on tissue turnover. Cell division is how-
ever a double-edged sword that needs to be tightly regu-
lated: by the dilution of damaged macromolecules it can
counteract chronological aging and lead to the genesis
of new functional cells, however excessive replication
places the organism at the risk of cancer.
Replicative cellular senescence was first described in
cell culture as an irreversible growth arrest triggered by
the accumulation of cell divisions in human fibroblasts
[3]. It has since been demonstrated in virtually all verte-
brate species and cell types that have been examined.
Telomere shortening due to replicative exhaustion was
the first cause of senescence to be well understood [4].
In the last decade, however, it has become evident that
cellular senescence can be triggered by many intrinsic
and extrinsic stimuli, including the activation of onco-
genes, ionizing and ultraviolet irradiation, reactive oxy-
gen species, pharmacological agents that modify DNA or* Correspondence: john_sedivy@brown.edu
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distribution, and reproduction in any mediumchromatin, and even nutrient imbalances and ill-
described cell culture stresses [5-9].
In spite of the plethora of stimuli, either or both of
two central signaling pathways leading to the activation
of the p53 and tumor suppressor retinoblastoma pro-
teins (pRB) are responsible for initiating and maintaining
the senescence state. Our knowledge of the senescence
phenotypes has also grown in detail, and includes the
manifestations of genotoxic stress, the secretion of
certain inflammatory cytokines and tissue remodeling
factors, and a distinctive type of facultative heterochro-
matin [10].
Recent data have implicated cellular senescence as an
important in vivo tumor suppression mechanism [11].
However, solid connections between cellular senescence
and organismal aging have been slower to emerge. An
important impediment has been the lack of reliable as-
says to distinguish senescent cells from the majority of
healthy but quiescent cells found in normal tissues.
While a few years ago it was questioned whether senes-
cent cells existed in vivo in appreciable numbers, today
it is increasingly evident that they accumulate with age
as well as at sites of age-associated pathologies. Implica-
tion of cellular senescence in stem cell aging has added
renewed credence for its importance in species with
considerable renewable tissues. Studies in mouse models
lacking p16Ink4a-positive senescent cells, as a result of
p16Ink4a gene inactivation or drug-induced cell clearance,
have implied a causal link between senescence and age-
related functional decline of tissues and organs [12].
This together with the discovery that some of the major
aging-related diseases are characterized by accumulationed Central Ltd. This is an Open Access article distributed under the terms of the
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therapeutic removal of senescent cells may improve
healthy lifespan. However, several recent studies suggest
that senescence may have evolutionarily critical func-
tions beyond cancer prevention [14], highlighting the
need for further characterization of senescent cell func-
tion at the level of the whole organism.
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